Leveraging an experienced team in cell therapy manufacture and logistics

A new manufacturing facility

Currently Autolus manufactures its product candidates at the Cell and Gene Therapy Catapult manufacturing facility in the UK.

For commercial supply, Autolus has a new manufacturing facility currently under construction. Planning approval was granted in 2021 to build the Company’s new 70,000 square foot facility in Stevenage, UK.

This new Stevenage facility which will allow for GMP capacity for approximately 2,000 batches a year initially, with scope to expand further.